CHRNA3 and non-small cell lung carcinoma: Furthermore, we found a trend for association with risk assessment and conditions, including NSCLC risk in males and rs833061 (VEGF –460) C/T polymorphisms, overall NSCLC and rs12914385 CHRNA3 C/T polymorphisms, overall NSCLC and rs8034191 (LOC123688) T/C polymorphisms and NSCLC risk in males and rs931794 G/A polymorphisms.